H2O America (HTO) Q3 2025 Filing Summary
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended September 30, 2025. In May 2025, the company changed its name from SJW Group to H2O America and its trading symbol to HTO on the Nasdaq Global Select Market. The company operates as a holding company for regulated water utilities in California, Connecticut, Maine, and Texas, serving approximately 407,000 connections and over 1.6 million people. The company operates under a single reportable segment, "Water Utility Services."
Key Financial Metrics (Nine Months Ended Sept 30, 2025)
| Metric | 2025 (9 Months) | 2024 (9 Months) | Change |
|---|---|---|---|
| Operating Revenue | $606.4 million | $550.6 million | +10.3% |
| Net Income | $86.4 million | $71.0 million | +21.6% |
| Diluted EPS | $2.48 | $2.18 | +13.8% |
| Operating Cash Flow | $181.3 million | $154.1 million | +17.7% |
| Capital Expenditures (Company-funded) | $351.1 million | $252.3 million | +39.2% |
| Total Debt (Long-term + Current) | $1.775 billion | $1.711 billion | +3.7% |
| Cash and Equivalents | $11.3 million | $9.7 million (Dec 31, 2024) | N/A |
Note: Q3 2025 Net Income was $45.1 million ($1.27 EPS) compared to $38.7 million ($1.17 EPS) in Q3 2024.
Material Changes vs. Prior Period
- Revenue Growth: Driven primarily by rate increases in California and Connecticut, offset partially by higher production costs. Water Utility Services revenue increased 10.8% year-over-year.
- Expense Increases: Total operating expenses rose 8.8% to $462.0 million. Water production expenses increased $20.2 million due to higher unit costs for purchased water and groundwater extraction, and decreased availability of lower-cost surface water.
- Capital Investment: Company-funded capital expenditures increased significantly to $351.1 million (74% of the 2025 budget of $473.0 million) compared to $252.3 million in the prior year.
- Dividends: Quarterly dividend increased to $0.42 per share from $0.40 in the prior year.
Guidance, Outlook, and Risks
- Acquisition Activity: On July 7, 2025, the company entered into agreements to acquire the regulated and wholesale water businesses of Quadvest for a base price of approximately $540 million ($483.6M + $56.4M). Closing is subject to regulatory approvals, including from the Public Utility Commission of Texas (PUCT), expected by mid-2026.
- Credit Rating: Standard & Poor's revised the outlook for H2O America, CTWS, and CWC from "Stable" to "Negative" on July 15, 2025, following the Quadvest acquisition announcement.
- Regulatory Matters:
- California: CPUC approved rate increases effective Jan 1, 2025, and July 1, 2025, to recover costs and fund infrastructure.
- Connecticut: PURA approved Water Infrastructure Conservation Adjustment (WICA) surcharges and a Water Quality and Treatment Adjustment (WQTA) for PFAS investments.
- Texas: PUCT approved System Improvement Charges (SIC) to increase revenue; a second amendment is pending.
- Legal Proceedings: The company is a plaintiff in Multi-District Litigation (MDL) against PFAS manufacturers. It received $21.2 million in settlement proceeds from 3M during the first nine months of 2025. Additional settlements with DuPont, Tyco, and BASF are pending.
- Water Supply: California water conditions remained positive with improved reservoir levels, though long-term supply challenges persist. Texas faces ongoing drought conditions but expects to meet demand.
Investor Verification Checklist
- Quadvest Acquisition Timeline: Verify the status of PUCT and other regulatory approvals required to close the $540M Quadvest deal, as delays could impact integration and financial projections.
- Production Cost Volatility: Monitor the impact of purchased water and groundwater extraction charges in California, which are subject to annual increases by Valley Water.
- PFAS Settlement Proceeds: Track the timing and amount of future cash proceeds from pending PFAS settlements (DuPont, Tyco, BASF) and their regulatory treatment (rate reduction vs. cost recovery).
- Capital Expenditure Execution: Confirm the company's ability to fund the remaining 2025 capital budget ($121.9M) and the projected $1.9B five-year plan, particularly the $300M allocated for PFAS treatment.
- Interest Rate Exposure: Assess the impact of rising interest rates on the company's variable-rate lines of credit and future debt issuances, given the "Negative" credit outlook.